97 related articles for article (PubMed ID: 4214866)
21. Glycosaminoglycans affect the interaction of human plasma kallikrein with plasminogen, factor XII and inhibitors.
Gozzo AJ; Nunes VA; Nader HB; Dietrich CP; Carmona AK; Sampaio MU; Sampaio CA; Araújo MS
Braz J Med Biol Res; 2003 Aug; 36(8):1055-9. PubMed ID: 12886459
[TBL] [Abstract][Full Text] [Related]
22. Significance of the regulation of plasma kallikrein by alpha 2M.
Colman RW
Ann N Y Acad Sci; 1994 Sep; 737():347-67. PubMed ID: 7524407
[No Abstract] [Full Text] [Related]
23. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
24. Effect of heparin on the activation of factor XII and the contact system in plasma.
Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
[TBL] [Abstract][Full Text] [Related]
25. The bradykinin-forming cascade and its role in hereditary angioedema.
Kaplan AP; Joseph K
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
[TBL] [Abstract][Full Text] [Related]
26. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with C1-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays.
Veloso D; Tseng SY; Craig AR; Colman RW
Adv Exp Med Biol; 1989; 247A():499-505. PubMed ID: 2481391
[No Abstract] [Full Text] [Related]
27. New insights into hereditary angio-oedema: Molecular diagnosis and therapy.
Nagy N; Grattan CE; McGrath JA
Australas J Dermatol; 2010 Aug; 51(3):157-62. PubMed ID: 20695852
[TBL] [Abstract][Full Text] [Related]
28. Studies on contact activation: effects of surface and inhibitors.
Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M
Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427
[TBL] [Abstract][Full Text] [Related]
29. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
[TBL] [Abstract][Full Text] [Related]
30. C1 inhibitor: the main inhibitor of human plasma kallikrein.
Trumpi-Kalshoven MM; Kluft C
Adv Biosci; 1978 Jul; 17():93-101. PubMed ID: 90628
[No Abstract] [Full Text] [Related]
31. Interrelationships of the fibrinolytic, coagulation, kinin generating and complement systems.
Schreiber AD; Austen KF
Ser Haematol; 1973; 6(4):593-600. PubMed ID: 4212102
[No Abstract] [Full Text] [Related]
32. Prekallikrein activation in the adult respiratory distress syndrome.
Schapira M; Gardaz JP; Py P; Lew PD; Perrin LH; Suter PM
Bull Eur Physiopathol Respir; 1985; 21(3):237-41. PubMed ID: 3873975
[TBL] [Abstract][Full Text] [Related]
33. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
Gluszko P; Undas A; Amenta S; Szczeklik A; Schmaier AH
J Lab Clin Med; 1994 Feb; 123(2):232-40. PubMed ID: 8301199
[TBL] [Abstract][Full Text] [Related]
34. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
Gallimore MJ; Friberger P
Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
[No Abstract] [Full Text] [Related]
35. Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin.
Derkx FH; Schalekamp MP; Bouma B; Kluft C; Schalekamp MA
J Clin Endocrinol Metab; 1982 Feb; 54(2):343-8. PubMed ID: 6459340
[TBL] [Abstract][Full Text] [Related]
36. Activation of the contact system in ascites from patients with gastrointestinal cancer.
Buø L; Karlsrud TS; Johansen HT; Aasen AO
Agents Actions Suppl; 1992; 38 ( Pt 2)():237-48. PubMed ID: 1281373
[TBL] [Abstract][Full Text] [Related]
37. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
Schmaier AH; Gustafson E; Idell S; Colman RW
J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
[TBL] [Abstract][Full Text] [Related]
38. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
[TBL] [Abstract][Full Text] [Related]
39. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
40. Interaction of plasma kallikrein with plasma proteinase inhibitors.
Salvesen G; Virca GD; Travis J
Adv Exp Med Biol; 1983; 156():121-30. PubMed ID: 6190363
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
